Thor Medical ASA (FRA:8NN)

Market Cap	231.14M +183.7%
Revenue (ttm)	70.89K
Net Income	-4.90M
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.6080
Previous Close	0.6480
Day's Range	0.6080 - 0.6080
52-Week Range	0.2240 - 0.6480
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Thor Medical ASA

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It offers thorium-228, as well as radium-224 and lead-212 to radiopharmaceutical customers. The company was incorporated in 2009 and is headquartered in Oslo, Norway.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2009
• Country: Norway
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 8NN

Financial Performance

Financial numbers in NOK

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 26, 2026

Data Sources Report a data error